This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Insiders Love Right Now

Forest Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Insiders are buying up a large amount of stock in Forest Laboratories (FRX), which develops, manufactures and sells branded forms of ethical drug products, most of which require a physician's prescription. Insiders are loading up on this stock into some modest strength, since shares are up over 14% so far in 2012.

Forest Laboratories has a market cap of $9.22 billion and an enterprise value of $6.65 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 12.05 and a forward price-to-earnings of 22.54. Its estimated growth rate for this year is -81.7%, and for next year it's pegged at 126.5%. This is an extremely cash-rich company, since the total cash position on its balance sheet is $2.5 billion and its total debt is zero.

>>5 Pharma Stocks Everyone Hates

Billionaire hedge fund manager and beneficial owner Carl Icahn just bought 1,962,011 shares, or about $67.05 million worth of stock, at $33.97 to $34.35 per share.

From a technical perspective, FRX is currently trading above both its 50-day and 200-day moving averages, which is bullish. Shares of FRX recently sold off from a high of $36.44 to a low of $31.28 with some above average selling volume. Following that low, shares of FRX have started to ramp higher and move back above both its 50-day and 200-day moving averages. That move has now pushed FRX back inside of its uptrend that had been intact before the recent selloff.

If you're bullish on FRX, then I would look for long-biased trades as long as this stock is trending above its 50-day moving average of $34.40 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average volume of 1.9 million shares as bullish. If FRX can maintain that trend, then this stock has a great chance of re-testing and possibly taking out its recent high of $36.44 a share.

On the flipside, I would avoid FRX or look for short-biased trades if this stock fails to hold that trend, and then drops back below some near-term support at $33.50 a share with heavy volume. If we see that action soon, then look for FRX to re-test and possibly take out its 200-day moving average of $32.80 a share.

2 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,031.14 +43.63 0.26%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs